StocksABIOMED IncABMD

ABMD

ABIOMED Inc

299.19 1.06 (0.36%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
298.89
B
299.68

Overview

Prev Close299.19
Day's Range296.15 - 299.17
52 Week Range233.27 - 383.56
Average Volume (3m)271.5K
1-Year Return21.60%
Beta0.8105
Market Cap13.55B
P/E Ratio60.6
Revenue847.52M
EPS4.9369
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.731/12/202016/03/202124/05/2021280.00300.00320.00340.00360.00
Chart times in UTC
Industry Medical Specialties
CEO Michael R. Minogue, MBA
Employees 1,725

FINANCIAL SUMMARY

For the quarter ended 31/3/2021, ABIOMED Inc's revenues increased by 4.14% and amounted to 241.25M. Net income decreased by 8.10% to 56.86M. Net assets increased by 5.41% to 1.33B and EPS decreased from 1.35 to 1.24.
ABMD's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
80.90%
Net Profit Margin
23.00%
Operating Margin
27.40%
Return On Investment
18.18%
06/20
09/20
12/20
03/21
Total Revenue
164.85M
209.76M
231.66M
241.25M
Gross Profit
128.87M
171.03M
190.55M
195.17M
Operating Income
35.77M
62.05M
72.25M
62.8M
Net Income
44.59M
62.21M
61.87M
56.86M